1. Home
  2. QNCX vs INVE Comparison

QNCX vs INVE Comparison

Compare QNCX & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • INVE
  • Stock Information
  • Founded
  • QNCX 2012
  • INVE 1990
  • Country
  • QNCX United States
  • INVE United States
  • Employees
  • QNCX N/A
  • INVE N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • INVE Computer peripheral equipment
  • Sector
  • QNCX Health Care
  • INVE Technology
  • Exchange
  • QNCX Nasdaq
  • INVE Nasdaq
  • Market Cap
  • QNCX 62.0M
  • INVE 86.5M
  • IPO Year
  • QNCX 2019
  • INVE 1997
  • Fundamental
  • Price
  • QNCX $1.42
  • INVE $3.51
  • Analyst Decision
  • QNCX Strong Buy
  • INVE Strong Buy
  • Analyst Count
  • QNCX 4
  • INVE 2
  • Target Price
  • QNCX $9.50
  • INVE $7.25
  • AVG Volume (30 Days)
  • QNCX 124.3K
  • INVE 34.6K
  • Earning Date
  • QNCX 03-31-2025
  • INVE 03-11-2025
  • Dividend Yield
  • QNCX N/A
  • INVE N/A
  • EPS Growth
  • QNCX N/A
  • INVE N/A
  • EPS
  • QNCX N/A
  • INVE 3.10
  • Revenue
  • QNCX N/A
  • INVE $104,217,000.00
  • Revenue This Year
  • QNCX N/A
  • INVE N/A
  • Revenue Next Year
  • QNCX N/A
  • INVE N/A
  • P/E Ratio
  • QNCX N/A
  • INVE $1.13
  • Revenue Growth
  • QNCX N/A
  • INVE 70.57
  • 52 Week Low
  • QNCX $0.51
  • INVE $2.95
  • 52 Week High
  • QNCX $2.45
  • INVE $9.24
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 37.52
  • INVE 44.12
  • Support Level
  • QNCX $1.37
  • INVE $3.50
  • Resistance Level
  • QNCX $1.69
  • INVE $3.67
  • Average True Range (ATR)
  • QNCX 0.12
  • INVE 0.19
  • MACD
  • QNCX -0.02
  • INVE 0.00
  • Stochastic Oscillator
  • QNCX 12.20
  • INVE 27.91

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

Share on Social Networks: